Biomedicine and the Human Condition

Challenges, Risks, and Rewards

How to avoid disease, how to breed successfully, and how to live to a reasonable age are questions that have perplexed humankind throughout history. This book explores our progress in understanding these challenges, and the risks and rewards of devising solutions. A broad range of topics are covered, including reproduction, the development of human progeny from conception to adulthood, staying healthy, ageing, cancer, infection and the burden of our genetic legacy.

 Reviews:

"Sargent's tale is rooted in science, but he sees the big picture as well. The story is epic but the language is a marvel of clarity. Knowledge empowers, and if this book were on prescription, it might improve the national health." Tim Radford, The Guardian

"Sargent has done a valuable service to those general readers--and not a few doctors--who wish to learn about the directions of current medical research. While 'biomedicine' may be only part of the story of disease and the human condition, those who want to know what the medical world is up to have got to start somewhere; Sargent's tip of the iceberg is a better place than most." The Lancet, Daivd Weatherall

"The journey is fascinating and written with a general audience in mind." New Scientist

"Biomedicine and the Human Condition is written in a compelling and lucid style that renders it accessible to the layperson, but it should become a valuable work of reference for many who are engaged professionally in medicine." Biochemist, Stephen Pollock

"Michael G. Sargent has written a terrific book for the lay reader who wants to discover how biomedicine has confronted the human challenges of maintaining good health."
Abstract

'Michael Sargent has done a great service by demonstrating that the rudiments of the essential scientific knowledge can be conveyed in a manner that is both informative and compelling. … his book conveys a humanitarian wisdom that can be placed in the scales to counterbalance the weight of dogmatic convictions. Biomedicine and the Human Condition is written in a compelling and lucid style that renders it accessible to the layperson, but it should also become a valuable work of reference for many who are engaged professionally in medicine. … It can be recommended to all preclinical medical students as a vade mecum and to busy clinicians as an up to the minute survey.' Stephen Pollock, Queen Mary College, University of London

'This is an interesting book for medics, bioscience students and historians of science and medicine at a reasonable price.' Biologist

'… very approachable … full of interesting facts and figures. … The breadth of this text is its strongest asset, and overall it is a worthwhile addition to any biomedical bookshelf.' Journal of Biological Education

'Michael Sargent offers an extremely thorough account of the scientific background to improvements in healthcare that followed achievements in clinical research and drug discovery in the 20th century. … [He] offers food for thought about the evolution of medical research and practice.' Times Higher Education Supplement

Reference Title: References

Reference Type: reference-list

Reference Type: reference-list

Harpending, H., and Rogers, A. (2000) Genetic perspectives on human origins and differentiation. Ann. Rev. Genomics Hum. Genet. 1, 361–85
Haviland, W. (2000) Human evolution and prehistory. Harcourt
Neiburger, E. J. (2000) Dentistry in ancient Mesopotamia. J. Mass. Dent. Soc. 49, 16–19
Keynes, R. (2002) Annie's Box. Fourth Estate
Coale, A. J. (1974) The history of the human population. Sci. Am. 231, 41
Eaton, S. B., and Konner, M. (1985) Palaeolithic nutrition: A consideration of its nature and current implications. N. Engl. J. Med. 312, 283–9
McClaren, A. (1978) Birth control in nineteenth century England. Croom Helm
Hardy, A. (2001) Health and medicine in Britain since 1860. Palgrave
Riley, J. (2001) Rising life expectancy: a global history. Cambridge University Press
Fisher, D. (1978) The Rockefeller Foundation and the development of scientific medicine in Great Britain. Minerva 16, 20–41
Tomes, N. (1998) The gospel of germs: Men, women, and the microbe in American life. Harvard University Press
Miles, A. (1966) The Lister Institute of Preventive Medicine 1891–1966. Nature 212, 559
Medawar, P. B. (1963) The MRC fifty years ago and now. Nature 200, 1039–43
Tuchman, B. (1962) The proud tower. MacMillan
Austoker, J. (1988) A history of the Imperial Cancer Research Fund, 1902–1986. Oxford University Press
Hare, R. (1970) The birth of penicillin. Allen and Unwin
Fosdick, R. (1952) The history of the Rockefeller Foundation. Harper
Corner, G. (1964) A history of the Rockefeller Institute. Rockefeller University Press
Edwards, R., and Steptoe, P. (1980) A matter of life. Hutchinson
Perut, M. F. (1999) Will medicine outgrow support? Nature 399, 299
Abelson, P. (1968) The advancement of the nation's health. Science 158, 51
Strickland, S. (1971) Integration of medical research and health policies. Science 173, 1093
Editorial. (1965) Does the United States have a science policy? Nature 217, 225–31
Kornberg, A. (1987) The NIH did it! Science 278, 1863
Strauss, S. (2000) www:nccam.nih.gov/ne/testimony/houseoflords.html
Doll, R. (1992) Sir Austin Bradford Hill and the progress of medical science. BMJ 305, 1521
Obituary. (2003) Louis Lasagna. BMJ 327, 565
Lewin, B. (1970) Second golden age of molecular biology. Nature 227, 1009–13
Smith, F. B. (1979) The peoples health 1830–1910. Holmes and Meier
Diamond, J. (1998) Guns, Germs, and Steel. Vintage
Shaw, G. B. (1911) Preface to The Doctors Dilemma. Penguin
Rosenberg, D., and Bloom, H. (1990) The Story of J. Faber and Faber
Youngson, A. J. (1979) The scientific revolution in Victorian medicine. Holmes and Meier
Loudon, I. (1992) The transformation of maternal mortality. BMJ 305, 1557
Rosenberg, K. R., and Trevathan, W. R. (2001) The evolution of human birth. Sci. Am. 285, 72–7
Cohen, J. (1996) Doctor James Young Simpson, Rabbi Abraham de Sola and Genesis Chapter 3, Verse 16. Obstetrics and Gynaecology 88, 895
Caton, D. (1996) Who said childbirth is natural? The medical mission of Grantly Dick Read. Anaesthesiology 84, 955–64
Behague, D. P., Victora, C. G., and Barros, F. C. (2002) Consumer demand for caesarean sections in Brazil. BMJ 324, 942–5
Short, R. V. (1976) The evolution of human reproduction. Proc. Roy. Soc. B. 195, 3
May, R. (1978) Human reproduction reconsidered. Nature 272, 491–5
Tanner, J. (1989) Foetus into man: Physical growth from conception to maturity. Castlemead
Short, R. (1984) Breast feeding. Sci. Am. 250, 23
Mepham, T. B. (1993) “Humanizing” milk: The formulation of artificial feeds for infants (1850–1910). Med. Hist. 37, 225–49
Smith, E. (1988) The retreat of tuberculosis, 1850–1950. Croom Helm
Cuthbertson, W. (2000) Evolution of infant nutrition. Brit. J. Nut. 81, 359–371
Forsyth, J., et al. (2003) Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood: Follow up of a randomised controlled trial. BMJ 326, 958–62
McNeill, W. (1976) Plagues and peoples. Basil Blackwell
CIA (2002) World Fact Book. www.cia.gov
Langer, W. (1974) Infanticide: A historical survey. Hist. Child. Q. (Winter), 353–66
Parliament. (1999) House of Commons research paper 99/111. House of Commons
McKeown, T. (1988) The origins of human disease. Basil Blackwell
Halsey, A. (1972) Trends in British society since 1900. Macmillan
Stevenson, J. (1984) British society 1914–45. Penguin
Djerassi, C. (1962) The Pill, pygmy chimps, and Degas' horse. Basic Books
Wardell, D. (1980) Margaret Sanger: Birth control's successful revolutionary. Am. J. Public Health 70, 736–42
Black, I. (2002) EU replaces cash denied to UN family planning by US. The Guardian, London, July 24
Harris, J. (1992) Clones, genes, and immortality
Editorial. (1968) Ethics and abortion. BMJ 2, 3
Paintin, D. (1985) Legal abortion in England and Wales. CIBA Foundation Symposium 115, 4–20
Ho, P. C. (2000) Emergency contraception: Methods and efficacy. Curr. Opin. Obstet. Gynecol. 12, 175–9
Ullman, A. (2000) The development of Mifepristone: A pharmaceutical drama in three acts. Am. Med. Women's Ass. 55 (suppl.) 117–120
Kolata, G. (1978) In vitro fertilization: Is it safe and repeatable? Science 201, 698
Trounson, A. L. J., Wood, C., Webb, J., and Wood, J. (1981) Pregnancies in humans by fertilization in vitro and embryo transfer in the controlled ovulatory cycle. Science 212, 681–2
Edwards, R., and Steptoe, P. (1983) Current status of in-vitro fertilisation and implantation of human embryos. The Lancet 2, 1265–9
Tesarik, J., and Mendoza, C. (1999) In vitro fertilization by intracytoplasmic sperm injection. Bioessays 21, 791–801
Powell, K. (2003) Seeds of doubt. Nature 422, 656–8
Gosden, R. (1999) Designer babies. Phoenix
Porcu, E., et al. (2000) Clinical experience and applications of oocyte cryopreservation. Mol. Cell. Endocrinol. 169, 33–7
Harris, R. (2002) Human babies in germ-line juggernaut. Current Biology 11, R539–40
Editorial. (1985) Powell bites dust: The British government needs to think hard about surrogacy. Nature 314, 568
Stromberg, B., et al. (2002) Neurological sequelae in children born after in-vitro fertilisation: A population-based study. Lancet 359, 461–5
Silver, L. (1998) Remaking Eden: Cloning, genetic engineering and the future of humankind? Phoenix
McCarty, M. (1985) The transforming principle. Norton
Judson, T. (1979) The eighth day of creation. Jonathan Cape
Olby, R. (2003) Quiet debut of the double helix. Nature 421, 402–5
Crick, F. (1993) Looking backwards: A birthday card for the double helix. Gene 135, 15–18
Griffith, J. S. (1967) Self-replication and scrapie. Nature 215, 1043–4
Prusiner, S. B. (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363–83
Melov, S., et al. (1999) Mitochondrial DNA rearrangements in ageing human brain and in situ PCR of mtDNA. Neurology. Ageing 20, 565–71
Wallace, D. C. (1997) Mitochondrial DNA in ageing and disease. Sci. Am. 277, 40–7
Gemmell, N. J., and Sin, F. Y. (2002) Mitochondrial mutations may drive Y chromosome evolution. Bioessays 24, 275–9
Ponamarev, M. V., et al. (2002) Active site mutation in DNA polymerase gamma associated with progressive external ophthalmoplegia causes error-prone DNA synthesis. J. Biol. Chem. 277, 15225–8
Melton, L. (2000) Womb wars. Sci. Am. 283, 24, 26
Yu, N., et al. (2002) Disputed maternity leading to identification of tetragametic chimerism N. Engl. J. Med. 346, 1545–52
Monod, J. (1972) Chance and Necessity. Collins
Crow, J. F. (1997) The high spontaneous mutation rate: Is it a health risk? Proc. Natl. Acad. Sci. USA 94, 8380–6
Friedberg, E. C. (2001) How nucleotide excision repair protects against cancer. Nature Rev. Cancer 1, 22–33
Bartek, J., and Lukas, J. (2003) Damage alert. Nature 421, 486–7
Crow, J. F. (2000) The origins, patterns and implications of human spontaneous mutation. Nat. Rev. Genet. 1, 40–7
Deininger, P. L., and Batzer, M. A. (1999) Alu repeats and human disease. Mol. Genet. Metab. 67, 183–93
Li, X., et al. (2001) Frequency of recent retrotransposition events in the human factor IX gene. Hum. Mutat. 17, 511–19
International Human Genome Sequencing Consortium. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860–921
Greaves, M. (2002) Childhood leukaemia. BMJ 324, 283–7
Nekrutenko, A., and Li, W. H. (2001) Transposable elements are found in a large number of human protein-coding genes. Trends Genet. 17, 619–21
Smit, A. F. (1999) Interspersed repeats and other mementoes of transposable elements in mammalian genomes. Curr. Opin. Genet. Dev. 9, 657–63
Symer, D. (2002) Human L1 retrotransposition is associated with genetic instability in vivo. Cell 110, 327–8
Hughes, V. M., and Datta, N. (1983) Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era. Nature 302, 725–6
Karaolis, D. K., Lan, R., Kaper, J. B., and Reeves, P. R. (2001) Comparison of Vibrio cholerae pathogenicity islands in sixth and seventh pandemic strains. Infect. Immun. 69, 1947–52
Stephens, C. and Murray, W. (2001) Pathogen evolution: How good bacteria go bad, Curr Biol 11, R53–6
Groisman, E. A., and Ochman, H. (1997) How Salmonella became a pathogen. Trends Microbiol. 5, 343–9
Herskind, A. M., et al. (1996) The heritability of human longevity: A population-based study of 2872 Danish twin pairs born 1870–1900. Hum. Genet. 97, 319–23
Iachine, I. A., et al. (1998) How heritable is individual susceptibility to death? The results of an analysis of survival data on Danish, Swedish and Finnish twins. Twin Res. 1, 196–205
Lichtenstein, P., et al. (2000) Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78–85
Weatherall, D. (1991) The new genetics and clinical practice. Oxford University Press
Marx, J. (2002) Unravelling the cause of diabetes. Science 296, 686–9
Cole, T. J. (2000) Secular trends in growth. Proc. Nutr. Soc. 59, 317–24
Brundtland, G. H., Liestol, K., and Walloe, L. (1980) Height, weight and menarcheal age of Oslo schoolchildren during the last 60 years. Ann. Hum. Biol. 7, 307–22
Floud, R., Wachter, K., and Gregory, A. (1990) Height, health and history. Cambridge University Press
Wilmoth, J. R., Deegan, L. J., Lundstrom, H., and Horiuchi, S. (2000) Increase of maximum life-span in Sweden, 1861–1999. Science 289, 2366–8
Alberts, B., et al., (2002) The molecular biology of the cell. Garland
Ridley, M. (2003) Nature via nurture. Fourth Estate
Porter, R. (1997) The greatest benefit to mankind. Oxford University Press
Masutomi, K., et al. (2003) Telomerase maintains telomere structure in normal human cells. Cell 114, 241–53
Wong, J. M., and Collins, K. (2003) Telomere maintenance and disease. Lancet 362, 983–8
Cohen, M., Lee, K. K., Wilson, K. L., and Gruenbaum, Y. (2001) Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem. Sci. 26, 41–7
Yaffe, M. (1999) The machinery of mitochondrial inheritance and behaviour. Science 283, 1493–7
Wallace, D. C. (1999) Mitochondrial diseases in man and mouse. Science 283, 1482–8
Marchington, D. R., et al. (1998) Evidence from human oocytes for a genetic bottleneck in an mtDNA disease. Am. J. Hum. Genet. 63, 769–75
Larson, J. E., and Cohen, J. C. (2000) Cystic fibrosis revisited. Mol. Genet. Metab. 71, 470–7
McNeil, P., Miyake, K., and Vogel, S. (2003) The endomembrane requirement for cell surface repair. PNAS 100, 4592–7
Brady, S. T. (1993) Motor neurons and neurofilaments in sickness and in health. Cell 73, 1–3
Winchester, B., Vellodi, A., and Young, E. (2000) The molecular basis of lysosomal storage diseases and their treatment. Biochem. Soc. Trans. 28, 150–4
Keller, J., Gee, J., and Ding, Q. (2002) The proteasome in brain ageing. Ageing Res. Rev. 1, 279–93
Wilmut, I., et al. (1997) Viable offspring derived from fetal and adult mammalian cells. Nature 385, 810–13
Levi-Montalcini, R. (1987) The nerve growth factor 35 years later. Science 237, 1154–62
Jacobson, M. D., Weil, M., and Raff, M. C. (1997) Programmed cell death in animal development. Cell 88, 347–54
Raff, M. C. (1992) Social controls on cell survival and cell death. Nature 356, 397–400
Krammer, P. H. (2000) CD95's deadly mission in the immune system. Nature 407, 789–95
Hetts, S. W. (1998) To die or not to die: An overview of apoptosis and its role in disease. JAMA 279, 300–7
Fleisher, T. A., Straus, S. E., and Bleesing, J. J. (2001) A genetic disorder of lymphocyte apoptosis involving the fas pathway: The autoimmune lymphoproliferative syndrome. Curr. Allergy Asthma Rep. 1, 534–40
Niederkorn, J. Y. (1999) The immune privilege of corneal allografts. Transplantation 67, 1503–8
Uckan, D., et al. (1997) Trophoblasts express Fas ligand: A proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod. 3, 655–62
Brash, D. (1996) Cellular proofreading. Nature Medicine 2, 525–6
Fadeel, B., Orrenius, S., and Zhivotovsky, B. (1999) Apoptosis in human disease: A new skin for the old ceremony? Biochem. Biophys. Res. Commun. 266, 699–717
Levine, A. (1997) p53 the cellular gatekeeper for growth and division. Cell 88, 323–31
Hayflick, L. (1994) How and why we age. Ballantine Books
Ferri, K. F., and Kroemer, G. (2001) Mitochondria – the suicide organelles. Bioessays 23, 111–15
Fuchs, E. (1997) Of mice and men: Genetic disorders of the cytoskeleton (Keith R. Porter Lecture, 1996). Mol. Biol. Cell 8, 189–203
Nicklas, R. B. (1997) How cells get the right chromosomes. Science 275, 632–7
Dynes, M. (2003) Miracle birth of the elusive baby found growing on mother's liver. The Times, May 24
Nilsson, L. (1990) A child is born. Dell
Brent, L., and Owen, R. (1996) A history of transplantation immunology. Academic Press
Barinaga, M. (2002) Cells exchanged during pregnancy live on. Science 296, 2169–72
Barker, D. (1998) Mothers, babies and health in later life. Churchill Livingston
Wolpert, L. (1991) The triumph of the embryo. Oxford University Press
Qumsiyeh, M. B., Kim, K. R., Ahmed, M. N., and Bradford, W. (2000) Cytogenetics and mechanisms of spontaneous abortions: Increased apoptosis and decreased cell proliferation in chromosomally abnormal villi. Cytogenet. Cell Genet. 88, 230–5
Griffin, D. K. (1996) The incidence, origin, and etiology of aneuploidy. Int. Rev. Cytol. 167, 263–96
Norimura, T., et al. (1996) p53-dependent apoptosis suppresses radiation-induced teratogenesis. Nat. Med. 2, 577–80
Heyer, B. S., MacAuley, A., Behrendtsen, O., and Werb, Z. (2000) Hypersensitivity to DNA damage leads to increased apoptosis during early mouse development. Genes Dev. 14, 2072–84
Stewart, R. J., Sheppard, H., Preece, R., and Waterlow, J. C. (1980) The effect of rehabilitation at different stages of development of rats marginally malnourished for ten to twelve generations. Br. J. Nutr. 43, 403–12
Gluckman, P. D. (2001) Editorial: Nutrition, glucocorticoids, birth size, and adult disease. Endocrinology 142, 1689–91
Lumbers, E. R., Yu, Z. Y., and Gibson, K. J. (2001) The selfish brain and the Barker hypothesis. Clin. Exp. Pharmacol. Physiol. 28, 942–7
Garofano, A., Czernichow, P., and Breant, B. (1997) In utero undernutrition impairs rat beta-cell development. Diabetologia 40, 1231–4
Kwong, W. Y., et al. (2000) Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension. Development 127, 4195–202
Butterworth, C. E., Jr., and Bendich, A. (1996) Folic acid and the prevention of birth defects. Ann. Rev. Nutr. 16, 73–97
Biever, C. (2003) Bring me sunshine. The New Scientist 179, 30–1
van der Meulen, J., et al. (1999) Fetal programming associated with the Dutch famine 1944–5. In Fetal Programming: Influences on Development and Disease in Later Life, ed. P. O'Brien, T. Wheeler, and D. J. P. Barker. Royal College of Obstetricians and Gynaecologists, pp. 45–56
Stein, Z., Susser, M., Saenger, G., and Marolla, F. (1975) Famine and human development: The Dutch hunger winter of 1944–1945. Oxford University Press
Boyd-Orr, J. (1936) Food, health and income. Macmillan
Eriksson, J., et al. (1999) Catch-up growth in childhood and death from coronary heart disease: Longitudinal study. BMJ 318, 427–31
Trowell, H., and Burkitt, D. (1981) Western diseases, their emergence and prevention. Harvard University Press
Diamond, J. (2003) The double puzzle of diabetes. Nature 423, 599–602
Prentice, A. (2003) Intrauterine factors, adiposity and hyperinsulinaemia. BMJ 327, 880–1
Porter, D. (1999) Health, civilisation and the state. Routledge
Le Fanu, J. (1999) The rise and fall of modern medicine. Little, Brown
Osmond, C., and Barker, D. J. (2000) Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women. Environ. Health. Perspect. 108 (suppl. 3) 545–53
Chandra, R. K. (1991) Interactions between early nutrition and the immune system. Ciba. Found. Symp. 156, 77–89
Moore, S. E., et al. (1997) Season of birth predicts mortality in rural Gambia. Nature 388, 434
Stephens, T., and Brynner, R. (2001) Dark remedy: The impact of thalidomide and its revival as a vital medicine. Perseus
Colborn, T., Dumanoski, D., and Myers, J. (1997) Our stolen future. Abacus
Ibarreta, D. and Swan, S. (2002) The DES story: Long term consequences of prenatal exposure. In The Precautionary Principle in the 20th Century: Late Lessons from Early Warnings, ed. Poul Harremoës et al. European Environment Agency, pp. 90–9
Kaiser, J. (2000) Endocrine disrupters: Panel cautiously confirms low-dose effects. Science 290, 695–7
Hunt, P. A., et al. (2003) Bisphenol exposure causes meiotic aneuploidy in the female mouse. Curr. Biol. 13, 546–53
Rennie, J. (1996) Perinatal management of the lower margin of viability. Arch. Dis. Child 74, F214–F218
Christie, B. (2000) Premature babies have high death and disability rate. BMJ 321, 467
Wickelgren, I. (2004) Resetting pregnancy's clock. Science 304, 666–8
Tin, W., Wariyar, U., and Hey, E. (1997) Changing prognosis for babies of less than 28 weeks' gestation in the north of England between 1983 and 1994. BMJ 314, 107–11
Avery, M. E. (2000) Surfactant deficiency in hyaline membrane disease: The story of discovery. Am. J. Respir. Crit. Care Med. 161, 1074–5
Uauy, R., and Hoffman, D. (2003) Essential fat requirements of preterm infants., Am. J. Clin. Nutr. 71, 245–50
Field, T. (1988) Stimulation of preterm infants. Pediatr. Rev. 10, 149–53
Schanberg, S. M., and Field, T. M. (1987) Sensory deprivation stress and supplemental stimulation in the rat pup and preterm human neonate. Child Dev. 58, 1431–47
Hack, M., and Merkatz, I. R. (1995) Preterm delivery and low birth weight – a dire legacy. N. Engl. J. Med. 333, 1772–4
Liu, Y., Albertsson-Wikland, K., and Karlberg, J. (2000) Long-term consequences of early linear growth retardation (stunting) in Swedish children. Pediatr. Res. 47, 475–80
Karlberg, J., and Luo, Z. C. (2000) Foetal size to final height. Acta Paediatr. 89, 632–6
Bogin, B. (1999) Patterns of human growth. Cambridge University Press
Janeway, C. A., Jr. (2001) How the immune system works to protect the host from infection: A personal view. Proc. Natl. Acad. Sci. USA 98, 7461–8
Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389–95
Carswell, E. A., et al. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666–70
McCormick, J. K., Yarwood, J. M., and Schlievert, P. M. (2001) Toxic shock syndrome and bacterial superantigens: An update. Ann. Rev. Microbiol. 55, 77–104
Libby, P. (2002) Atherosclerosis: The new view. Sci. Am. 286, 46–55
Yazdanbakhsh, M., Kremsner, P. G., and van Ree, R. (2002) Allergy, parasites, and the hygiene hypothesis. Science 296, 490–4
Martinez, F. D., and Holt, P. G. (1999) Role of microbial burden in aetiology of allergy and asthma. Lancet 354 (suppl. 2). SII12–15
Mackay, I. R. (2000) Tolerance and autoimmunity. BMJ 321, 93–6
Goldbach-Mansky, R., and Lipsky, P. E. (2003) New concepts in the treatment of rheumatoid arthritis. Ann. Rev. Med. 54, 197–216
Todd, J. A. (2001) Human genetics: Tackling common disease. Nature 411, 537, 539
Ye, X. et al. (2000) Engineering the provitamin A (beta-carotene) biosynthetic pathway into (carotenoid-free) rice endosperm. Science 287, 303–5
Rajakumar, K. (2000) Pellagra in the United States: A historical perspective. South. Med. J. 93, 272–7
Chan, A. C. (1998) Vitamin E and atherosclerosis. J. Nutr. 128, 1593–6
Bang, H. O., and Dyerberg, J. (1981) Personal reflections on the incidence of ischaemic heart disease in Oslo during the Second World War. Acta. Med. Scand. 210, 245–8
Connor, W. E. (2000) Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 71, 171S–5S
Lamartiniere, C. A. (2000) Protection against breast cancer with genistein: A component of soy. Am. J. Clin. Nutr. 71, 1705S–7S; discussion 1708S–9S
Taubes, G. (2001) Nutrition: The soft science of dietary fat. Science 291, 2536–45
Fahey, J. W., Zhang, Y., and Talalay, P. (1997) Broccoli sprouts: An exceptionally rich source of inducers of enzymes that protect against chemical carcinogens. Proc. Natl. Acad. Sci. USA 94, 10367–72
Brosens, J., and Parker, M. (2003) Oestrogen receptor hikacked. Nature 423, 487–8
Kogevinas, M. (2001) Human health effects of dioxins: Cancer, reproductive and endocrine system effects. Hum. Reprod. Update 7, 331–9
Ames, B., Magaw, R., and Gold, L. (1987) Ranking possible carcinogenic hazards. Science 236, 271–280
Janeway, C., Travers, P., Walport, M., and Shlomchik, M. (2001) Immunobiology. Garland Publishing
Tuljapurkar, S., Li, N., and Boe, C. (2000) A universal pattern of mortality decline in the G7 countries. Nature 405, 789–92
Kirkwood, T. B., and Austad, S. N. (2000) Why do we age? Nature 408, 233–8
Holliday, R. (1995) Understanding ageing. Cambridge University Press
Hayflick, L. (2000) The future of ageing. Nature 408, 267–9
Davey, B., Halliday, T., and Hirst, M. (2001) Human biology and health: An evolutionary approach. Open University
Harman, D. (1956) Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956 11, 298–300
Beckman, K. B., and Ames, B. N. (1998) The free radical theory of aging matures. Physiol. Rev. 78, 547–81
Melov, S., et al. (2000) Extension of life-span with superoxide dismutase/catalase mimetics. Science 289, 1567–9
McKenzie, D., et al. (2002) Mitochondrial DNA deletion mutations: A causal role in sarcopenia. Eur. J. Biochem. 269, 2010–15
Brunk, U. T., and Terman, A. (2002) The mitochondrial-lysosomal axis theory of aging: Accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur. J. Biochem. 269, 1996–2002
Suter, M., et al. (2000) Age-related macular degeneration: The lipofusion component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells. J. Biol. Chem. 275, 39625–30
Dirks, A. and Leeuwenburgh, C. (2002) Apoptosis in skeletal muscle with aging. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282, R519–27
Lamberts, S. W., van den Beld, A. W., and van der Lely, A. J. (1997) The endocrinology of aging. Science 278, 419–24
Rudman, D., et al. (1990) Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323, 1–6
Laron, Z. (2002) Effects of growth hormone and insulin-like growth factor 1 deficiency on ageing and longevity. Novartis Found. Symp. 242, 125–37; discussion 137–42
Yen, S. S. (2001) Dehydroepiandrosterone sulfate and longevity: New clues for an old friend. Proc. Natl. Acad. Sci. USA 98, 8167–9
Lane, M. A., Ingram, D. K., Ball, S. S., and Roth, G. S. (1997) Dehydroepiandrosterone sulfate: A biomarker of primate aging slowed by calorie restriction. J. Clin. Endocrinol. Metab. 82, 2093–6
Lord, J. M., et al. (2001) Neutrophil ageing and immunesenescence. Mech. Ageing Dev. 122, 1521–35
Finkel, T., and Holbrook, N. J. (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408, 239–47
Finch, C. E., and Tanzi, R. E. (1997) Genetics of aging. Science 278, 407–11
Perls, T. T. (1995) The oldest old. Sci. Am. 272, 70–5
Martin, G. M., and Oshima, J. (2000) Lessons from human progeroid syndromes. Nature 408, 263–6
Hsin, H., and Kenyon, C. (1999) Signals from the reproductive system regulate the lifespan of C. elegans. Nature 399, 362–6
Hamilton, M. L., et al. (2001) Does oxidative damage to DNA increase with age? Proc. Natl. Acad. Sci. USA 98, 10469–74
Kayo, T., Allison, D. B., Weindruch, R., and Prolla, T. A. (2001) Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys. Proc. Natl. Acad. Sci. USA 98, 5093–8
Cristofalo, V. J., et al. (1998) Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation, Proc. Natl. Acad. Sci. USA 95, 10614–9
Faragher, R. G., and Kipling, D. (1998) How might replicative senescence contribute to human ageing? Bioessays 20, 985–91
Kassem, M., et al. (1997) Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporosis Int. 7, 514–24
Hayflick, L. (2002) DNA replication and traintracks. Science 296, 1611–12
von Zglinicki, T. (2001) Telomeres and replicative senescence: Is it only length that counts? Cancer Lett. 168, 111–16
Shay, J. W., and Wright, W. E. (2001) Ageing and cancer: The telomere and telomerase connection. Novartis Found. Symp. 235, 116–25; discussion 125–9, 146–9
Johnson, F. B., Marciniak, R. A., and Guarente, L. (1998) Telomeres, the nucleolus and aging. Curr. Opin. Cell Biol. 10, 332–8
Schwarcz, J. (2001) The genie in the bottle. Freeman
Lock, S. (1983) “O that I were young again”: Yeats and the Steinach operation. Br. Med. J. (Clin. Res. Ed.) 287, 1964–8
Alcor Life Extension Foundation. (2000). www.alcor.org
deGrey, A., et al. (2003) Antiageing technology and pseudoscience. Science 296, 5568–9
Hall, S. (2003) In vivo vitalis? Compounds activate life-extending genes. Science 301, 1165
Kirkwood, T. The time of our lives. Weidenfeld and Nicholson
Rettig, R. (1977) Cancer crusade. Princeton University Press
Weisburger, E. K. (1989) Current carcinogen perspectives: De minimis, Delaney and decisions. Sci. Total Environ. 86, 5–13
Stehelin, D., Varmus, H. E., Bishop, J. M., and Vogt, P. K. (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260, 170–3
Culliton, B. (1972) Cancer virus theories: Focus of research debate. Science 177, 44–7
Peto, J. (2001) Cancer epidemiology in the last century and the next decade. Nature 411, 390–5
Hanahan, D., and Weinberg, R. A. (2000) The hallmarks of cancer. Cell 100, 57–70
Look, A. (1997) Oncogenic transcription factors in the human acute leukaemias. Science 278, 1059–64
Marx, J. (2003) Mutant stem cells may seed cancer. Science 301, 1308–10
Campisi, J. (2000) Cancer, aging and cellular senescence. In Vivo 14, 183–8
Artandi, S. E., and DePinho, R. A. (2000) A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr. Opin. Genet. Dev. 10, 39–46
Nordstrom, D. K. (2002) Public health. Worldwide occurrences of arsenic in ground water. Science 296, 2143–5
Ames, B. N. (1979) Identifying environmental chemicals causing mutations and cancer. Science 204, 587–93
Ohshima, H., and Bartsch, H. (1994) Chronic infections and inflammatory processes as cancer risk factors: Possible role of nitric oxide in carcinogenesis. Mutat. Res. 305, 253–64
Iversen, L. (2001) Drugs: A very short introduction. Oxford University Press
Weinberg, R. (1997) Racing to the start of the road: The search for the origin of cancer. Bantam
Peto, R., et al. (1992) Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. Lancet 339, 1268–78
Kmietowicz, Z. (2001) Tobacco company claims that smokers help the economy. BMJ 323, 126
Scotto, J., and Bailar, J. (1969) Rigoni-Stern and medical statistics: A nineteenth-century approach to cancer research. J. Hist. Med. Allied Sci. 24, 65–75
Pierce, D. A., et al. (1996) Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950–1990. Radiat. Res. 146, 1–27
Obituary. (2002) Dr. Alice Stewart. New York Times
Goldman, M. (1996) Cancer risk of low-level exposure. Science 271, 1821–2
Coussens, L. M., and Werb, Z. (2002) Inflammation and cancer. Nature 420, 860–7
Gee, D., and M. Greenberg. (2002) Asbestos: From ‘magic’ to malevolent mineral. In The Precautionary Principle in the 20th Century: Late Lessons from Early Warnings, ed. Poul Harremoës et al. European Environment Agency, pp. 49–63
Ferber, D. (2002) Virology: Monkey virus link to cancer grows stronger. Science 296, 1012–15
Ames, B. N. (1999) Cancer prevention and diet: Help from single nucleotide polymorphisms. Proc. Natl. Acad. Sci. USA 96, 12216–8
Blacklock, C. J., et al. (2001) Salicylic acid in the serum of subjects not taking aspirin: Comparison of salicylic acid concentrations in the serum of vegetarians, non-vegetarians, and patients taking low dose aspirin. J. Clin. Pathol. 54, 553–5
Doll, R., and Armstrong, B. (1980) Cancer. In Western Diseases, Their Emergence and Prevention, ed. H. Trowell and D. Burkitt. Harvard University Press, pp. 93–112
Leaf, C. (2004) Why we're losing the war on cancer and how to win. Fortune, March 22, 42–9
Drancourt, M., and Raoult, D. (2002) Molecular insights into the history of plague. Microbes Infect. 4, 105–9
Halleyday, S. (1999) The great stink of London: Sir Joseph Bazalgette and the cleansing of the Victorian metropolis. Sutton Publishing
Daniel, T. M. (2000) The origins and precolonial epidemiology of tuberculosis in the Americas: Can we figure them out? Int. J. Tuberc. Lung Dis. 4, 395–400
Baxby, D. (1996) Two hundred years of vaccination. Curr. Biol. 6, 769–72
Baker, J. P. (2000) Immunization and the American way: Four childhood vaccines. Am. J. Public Health. 90, 199–207
Vitek, C. R., and Wharton, M. (1998) Diphtheria in the former Soviet Union: Reemergence of a pandemic disease. Emerg. Infect. Dis. 4, 539–50
Robertson, S. E., et al. (1996) Yellow fever: A decade of re-emergence. JAMA 276, 1157–62
Meldrum, M. (1998) “A calculated risk”: The Salk polio vaccine field trials of 1954. BMJ 317, 1233–6
Blume, S., and Geesink, I. (2000) A brief history of polio vaccines. Science 288, 1593–4
Nathanson, N., and Fine, P. (2002) Virology: Poliomyelitis eradication–a dangerous endgame. Science 296, 269–70
Weiss, R. A. (2001) Animal origins of human infectious disease (Leeuwenhoek Lecture 2001). Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 957–77
Ferber, D. (2002) Public health: Creeping consensus on SV40 and polio vaccine. Science 298, 725–7
Behr, M. A. (2001) Comparative genomics of BCG vaccines. Tuberculosis (Edinb.) 81, 165–8
Weiner, D. B., and Kennedy, R. C. (1999) Genetic vaccines. Sci. Am. 281, 50–7
Madsen, K. M., et al. (2002) A population-based study of measles, mumps, and rubella vaccination and autism. N. Engl. J. Med. 347, 1477–82
Loudon, I. (1987) Puerperal fever, the streptococcus, and the sulphonamides, 1911–1945. BMJ 295, 485–490
Levy, S. B. (1998) The challenge of antibiotic resistance. Sci. Am. 278, 46–53
Ferber, D. (2003) WHO advises kicking the livestock antibiotic habit. Science 301, 1027
Crisostomo, M. I., et al. (2001) The evolution of methicillin resistance in Staphylococcus aureus: Similarity of genetic backgrounds in historically early methicillin-susceptible and – resistant isolates and contemporary epidemic clones. Proc. Natl. Acad. Sci. USA 98, 9865–70
Ferber, D. (2002) Livestock feed ban preserves drug's power. Science 295, 27–8
Clarke, T. (2003) Drug companies snub antibiotics as pipeline threatens to run dry. Nature 425, 225
Reid, S. D., et al. (2000) Parallel evolution of virulence in pathogenic Escherichia coli. Nature 406, 64–7
Eisen, J. A. (2001) Gastrogenomics. Nature 409, 463, 465–6
Pupo, G. M., Lan, R., and Reeves, P. R. (2000) Multiple independent origins of Shigella clones of Escherichia coli and convergent evolution of many of their characteristics. Proc. Natl. Acad. Sci. USA 97, 10567–72
Starr, D. (1999) Blood. Warner
Defrancesco, L. (2002) US in grip of West Nile Virus. Nature Medicine 8, 1051
Cyranoski, D., and Abbott, A. (2003) Virus detectives seek source of SARS in China's wild animals. Nature 423, 467
Balter, M. (2000) Emerging diseases: On the trail of Ebola and Marburg viruses. Science 290, 923–5
Berche, P. (2001) The threat of smallpox and bioterrorism. Trends Microbiol. 9, 15–18
Cosby, A. (1989) America's forgotten pandemic. Cambridge University Press
Taubenberger, J. K., Reid, A. H., and Fanning, T. G. (2000) The 1918 influenza virus: A killer comes into view. Virology 274, 241–5
Webster, R. (2001) A molecular whodunit. Science 293, 1773–5
Shortridge, K. F. (1999) The 1918 ‘Spanish’ flu: Pearls from swine? Nat. Med. 5, 384–5
Kilbourne, E. D. (1997) In pursuit of influenza: Fort Monmouth to Valhalla (and back). Bioessays 19, 641–50
Pruisner, S., Montaingner, L., and Gallo, R. (2002) Discovering the cause of AIDS. Science 298, 1726–31
Hillis, D. (2000) Origins of HIV. Science 288, 1757–8
Marx, P., Alcabes, P., and Drucker, E. (2001) Serial human passage of simian immunodeficiency virus by unsterile injections and the emergence of epidemic HIV in Africa. Phil. Trans. Roy. Soc. 356, 911–20
Hooper, E., (2000) The river: A journey back to the source of HIV and AIDS. Penguin
Weiss, R. A. (2001) Polio vaccines exonerated. Nature 410, 1035–6
Richman, D. D. (2001) HIV chemotherapy. Nature 410, 995–1001
Weller, I. V., and Williams, I. G. (2001) ABC of AIDS: Antiretroviral drugs. BMJ 322, 1410–12
Collinge, J. (1999) Variant Creutzfeldt-Jakob disease. Lancet 354, 317–23
Zobeley, E., et al. (1999) Infectivity of scrapie prions bound to a stainless steel surface. Mol. Med. 5, 240–3
Sun, M. (1985) Gene-spliced hormone for growth approved. Science 230, 523
Ghani, A. C., Ferguson, N. M., Donnelly, C. A., and Anderson, R. M. (2003) Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK. Proc. R. Soc. Lond. B. Biol. Sci. 270, 689–98
Mead, S., Stumpf, M., and Whitfield, J. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300, 640–3
Carter, R., and Mendis, K. N. (2002) Evolutionary and historical aspects of the burden of malaria. Clin. Microbiol. Rev. 15, 564–94
Spielman, A., and D'Antonio, M. (2001) Mosquito: The story of mans deadliest foe. Faber and Faber
Gubler, D. J., (2004) Cities spawn epidemic dengue viruses. Nature, Medicine 10, 129–30
Packard, R. M., and Gadehla, P. (1997) A land filled with mosquitoes: Fred L. Soper, the Rockefeller Foundation, and the anopheles gambiae invasion of Brazil. Med. Anthropol. 17, 215–38
Zajtchuk, R. (1997) Textbook of military medicine: Medical aspects of chemical and biological warfare. http://www.vnh.org/MedAspChemBioWar/ chapters
Meselson, M., et al. (1994) The Sverdlovsk anthrax outbreak of 1979. Science 266, 1202–8
Henderson, D. A. (1999) The looming threat of bioterrorism. Science 283, 1279–82
Check, E. (2002) Poliovirus advance sparks fears of data curbs. Nature 418, 265
Sneador, W. (1985) Drug discovery: The evolution of modern medicines. Wiley
Tulp, M., and Bohlin, L. (2002) Functional versus chemical diversity: Is biodiversity important for drug discovery? Trends Pharmacol. Sci. 23, 225–31
Plunkett, M. J., and Ellman, J. A. (1997) Combinatorial chemistry and new drugs. Sci. Am. 276, 68–73
Moellering, R. C., Jr. (1999) A novel antimicrobial agent joins the battle against resistant bacteria. Ann. Intern. Med. 130, 155–7
Haseltine, W. A. (2001) Beyond chicken soup. Sci. Am. 285, 56–63
Fabbro, D., et al. (2002) Protein kinases as targets for anticancer agents: From inhibitors to useful drugs. Pharmacol. Ther. 93, 79–98
Pfeffer, N. (1993) The stork and the syringe: A political history of reproductive medicine. Polity Press
Pilcher, H. (2003) The ups and downs of Lithium. Nature 425, 118–120
Healy, D. (2003) The creation of psychopharmacology. Harvard University Press
Bodenheimer, T. (2000) Uneasy alliance – clinical investigators and the pharmaceutical industry. N. Engl. J. Med. 342, 1539–44
Dyer, O. (2001) University accused of violating academic freedom to safeguard funding from drug companies. BMJ 323, 591
Safer, D. J. (2000) Are stimulants overprescribed for youths with ADHD? Ann. Clin. Psychiatry 12, 55–62
Vane, J. (1994) Towards a better aspirin. Nature 367, 215–16
Editorial. (2003) How a statin might destroy a drug company. The Lancet 361, 793
Henry, D., and Lexchin, J. (2002) The pharmaceutical industry as a medicines provider. The Lancet 16, 1590–5
Alper, J. (2003) Biotech thinking comes to academic medical centres. Science 299, 1303–5
Goeddel, D. V., and Levinson, A. D. (2000) Robert A. Swanson (1947–99). Nature 403, 264
Hall, S., (1988) Invisible frontiers. Atlantic
Vajo, Z., Fawcett, J., and Duckworth, W. C. (2001) Recombinant DNA technology in the treatment of diabetes: Insulin analogs. Endocr. Rev. 22, 706–17
Barinaga, M. (2000) Asilomar revisited: Lessons for today? Science 287, 1584–5
Kornberg, A. (1995) The golden helix: Inside biotech ventures. University Science Books
Dalton, R., and Schiermeier, Q. (1999) Genentech pays $200m over growth hormone ‘theft’. Nature 402, 335
Maeder, T. (2003) The orphan drug backlash. Sci. Am. 288, 70–7
Lahteenmaki, R., and Fletcher, L. (2002) Public biotechnology 2001 – the numbers. Nat. Biotechnol. 20, 551–5
Agres, T. (2003) Licenses worth a billion. The Scientist 17, 55
Ziomek, C., (1998) Commercialisation of proteins produced in the mammary gland. Theriogeniology 49, 139
Steinberg, F. M., and Raso, J. (1998) Biotech pharmaceuticals and biotherapy: An overview. J. Pharm. Pharm. Sci. 1, 48–59
Ezzell, C. (2001) Magic bullets fly again. Sci. Am. 285, 34–41
Stevens, D. L., et al. (1996) Group A streptococcal bacteremia: The role of tumor necrosis factor in shock and organ failure. J. Infect. Dis. 173, 619–26
Inoue, N., Takeuchi, M., Ohashi, H., and Suzuki, T. (1995) The production of recombinant human erythropoietin. Biotechnol. Annu. Rev. 1, 297–313
Pfeffer, L., et al. (1998) Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res. 58, 2489–99
Gutterman, J. (1994) Cytokine therapeutics: Lessons from interferon alpha. Proc. Nat'l. Acad. Sci. 91, 1198–1205
Brown, J. B. (1986) Gonadotrophins. In Infertility: Male and Female, ed. V. Insier and B. Lunenfield. Churchill Livingston, pp. 000–000
Laffan, M., and Tuddenham, E. (1998) Science, medicine, and the future: Assessing thrombotic risk. BMJ 317, 520–3
DeFrancesco, L. (2001) First sepsis drug nears market. Nature 7, 516–17
Lu, Y., et al. (2001) Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Circulation 104, 594–9
Griffioen, A. W., and Molema, G. (2000) Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52, 237–68
Li, R. H., and Wozney, J. M. (2001) Delivering on the promise of bone morphogenetic proteins. Trends Biotechnol. 19, 255–65
Teitelbaum, S. L., and Ross, F. P. (2003) Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638–49
Chiurel, M. (2000) Whatever happened to leptin. Nature 404, 538–40
Mattson, M. P. (2001) Lose weight STAT: CNTF tops leptin. TINS 24, 313–14
Tomalin, C. (2002) Samuel Pepys: The unequalled self. Penguin Viking
Hess, J., and Schmidt, P. (1984) The first blood banker: Oswald Hope Robertson. Transfusion 24, 404–7
Obituary. (2000) Rene Favaloro. The Times (London), July 31
Green, H. (1991) Cultured cells for the treatment of disease. Sci. Am. 265, 96–102
Petit-Zeman, S. (2001) Regenerative medicine. Nature Biotechnology 19, 201–6
Rodan, G. M., TJ. (2000) Therapeutic approaches to bone diseases. Science 289, 1508
Lindahl, A., Brittberg, M., and Peterson, L. (2003) Cartilage repair with chondrocytes: Clinical and cellular aspects. Novartis Found. Symp. 249, 175–86
Oberpenning, F., Meng, J., Yoo, J. J., and Atala, A. (1999) De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat. Biotechnol. 17, 149–55
Griffith, L. G., and Naughton, G. (2002) Tissue engineering – current challenges and expanding opportunities. Science 295, 1009–14
Dynes, M. (2003) Heart transplant secret of the hospital gardiner. The Times (London), April 26
Dyer, C. (1999) English teenager given heart transplant against her will. BMJ 319, 209
Mayes, T. (2003) Ailing tycoon buys Pakistan girl's kidney. The Sunday Times (London), March 23
Mufson, S. (2001) Chinese doctor tells of organ removals after executions. Washington Post, June 27, p. A1
Platt, J. L. (2000) Xenotransplantation: New risks, new gains. Nature 407, 27, 29–30
Buhler, L., et al. (2001) Transplantation of islets of Langerhans: New developments. Swiss Med. Wkly. 131, 671–80
Lumelsky, N., et al. (2001) Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 292, 1389–94
Good, R. A., Gatti, R. A., Hong, R., and Meuwissen, H. J. (1969) Graft treatment of immunological deficiency. Lancet 1, 1162
Good, R. (1971) Immunodeficiency in developmental perspective. The Harvey Lectures, series 67, 1–107
Parkman, R. (1986) The application of bone marrow transplantation to the treatment of genetic diseases. Science 232, 1373–8
Gluckman, E., et al. (1989) Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N. Engl. J. Med. 321, 1174–8
Barinaga, M. (2000) Fetal neuron grafts pave the way for stem cell therapies. Science 287, 1421–2
Li, Y., Field, P., and Raisman, G. (1997) Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277, 2000–2
Thomson, J. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–7
Marshall, E. (2000) The business of stem cells. Science 287, 1419–21
Aldous, P. (2001) Can they rebuild this? Nature 410, 622–5
Manouvrier-Hanu, S., Holder-Espinasse, M., and Lyonnet, S. (1999) Genetics of limb anomalies in humans. TIGS 15, 409–17
Eldadah, Z. A., et al. (2001) Familial tetralogy of fallot caused by mutation in the jagged gene. Hum. Mol. Genet. 10, 163–9
Rosner, F. (1969) Hemophilia in the Talmud and rabbinic writings. Ann. Intern. Med. 70, 833–7
Roth, E. F., Raventos-Suarez, C., Rinaldi, A., and Nagel, R. L. (1983) Glucose-6-phosphate dehydrogenase deficiency inhibits in vitro growth of Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 80, 298–9
Chakravarti, A., and Chakraborty, R. (1978) Elevated frequency of Tay-Sachs disease among Ashkenazic Jews unlikely by genetic drift alone. Am. J. Hum. Genet. 30, 256–61
Hogenauer, C., et al. (2000) Active intestinal chloride secretion in human carriers of cystic fibrosis mutations: An evaluation of the hypothesis that heterozygotes have subnormal active intestinal chloride secretion. Am. J. Hum. Genet. 67, 1422–7
Kuper, A. (2003) Incest, cousin marriage, and the origin of the human sciences in the nineteenth century. Past and Present Society 174, 155–83
Gibbons, A. (1993) The risks of inbreeding. Science 259, 1252
Cao, A., and Rosatelli, M. C. (1993) Screening and prenatal diagnosis of the haemoglobinopathies. Baillieres Clin. Haematol. 6, 263–86
Modell, B., and Darr, A. (2002) Genetic counselling and customary consanguineous marriage. Nature, Genetics 3, 225–9
Kaback, M. M. (2001) Screening and prevention in Tay-Sachs disease: Origins, update, and impact. Adv. Genet. 44, 253–65
Ekstein, J., and Katzenstein, H. (2001) The Dor Yeshorim story: Community-based carrier screening for Tay-Sachs disease. Adv. Genet. 44, 297–310
Handyside, A. H., Kontogianni, E. H., Hardy, K., and Winston, R. M. (1990) Pregnancies from biopsied human preimplantation embryos sexed by Y-specific DNA amplification. Nature 344, 768–70
Rifkin, J., (1998) The biotech century. Victor Gollanz
Editorial. (1994) China's misconception of eugenics. Nature 367, 3
Kumar, S. (2003) Ratio of girls to boys in India continues to decline. BMJ 327, 1007
Crockin, S. (2001) Adam Nash: Legally speaking, a happy ending or slippery slope? Reprod. Biomed. Online 2, 6–7
Levy, N. (2002) Deafness, culture and choice. J. Med. Ethics 28, 284–5
Shakespeare, T. (2003) How perfect do we want our babies to be?, The Sunday Times (London), November 23
Dyer, C. (2000) Appeal court bars sterilisation of woman with learning disabilities. The Guardian, May 19
Papadopoulos, G. K., Wijmenga, C., and Koning, F. (2001) Interplay between genetics and the environment in the development of celiac disease: Perspectives for a healthy life. J. Clin. Invest. 108, 1261–6
Cohen, F. E. and Kelly, J. W. (2003) Therapeutic approaches to protein misfolding diseases. Nature 426, 405–9
Anderson, W. F. (1992) Human gene therapy. Science 256, 808–13
Williams, D., and Baum, C. (2003) Medicine: Gene therapy – new challenges ahead. Science 302, 400–1
Ferber, D. (2001) Gene therapy: Safer and virus-free? Science 294, 1638–42
Stock, G., and Campbell, J., (2000) Engineering the human germline: An exploration of the science and ethics of altering the genes we pass to our children. Oxford University Press
Lindee, M. (2003) Watson's world. Science 300, 432–4
McLaren, A. (1998) Correspondence. Nature 392, 645
Nielsen, T. (1997) Human germline therapy. McGill Journal of Medicine 3, 126–132
Peltonen, L., and McKusick, V. A. (2001) Genomics and medicine: Dissecting human disease in the postgenomic era. Science 291, 1224–9
Evans, W. E., and Relling, M. V. (1999) Pharmacogenomics: Translating functional genomics into rational therapeutics. Science 286, 487–91
Wolf, C., Smith, G., and Smith, R. L. (2000) Science, medicine, and the future: Pharmacogenetics. BMJ 320, 987
Mossialos, E., and Dixon, A. (2001) Genetic testing and insurance: Opportunities and challenges for society. Trends Mol. Med. 7, 323–4
Ridley, M. (1999) Genome: The autobiography of a species in 23 chapters. Fourth Estate
Appleyard, B. (1999) Brave new worlds. HarperCollins
Charatan, F. (2001) US spending on prescription drugs rose by 19% in 2000. BMJ 322, 1198
Gottlieb, S. (2002) Congress criticises drugs industry for misleading advertising. BMJ 325, 1379
Binswanger, H. (2003) HIV/AIDS treatment for millions. Science 292, 221
Cohen, J. (2003) Companies, donor's pledge to close gap in AIDS treatment. Science 289, 368
Caplan, A. (2004) Is biomedical research too dangerous to pursue? Science 303, 1142